Rhenman & Partners Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Rhenman & Partners Asset Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-221,255	Closed	-$8.61M	–	94
2023 Q1	$8.61M	Buy	221,255 +25,384	+13%	+$1.24M	0.95%	35
2022 Q4	$10.4M	Buy	195,871 +40,871	+26%	+$1.99M	1.08%	34
2022 Q3	$6.83M	Sell	155,000 -20,000	-11%	-$860K	0.72%	50
2022 Q2	$6.37M	Buy	175,000 +25,000	+17%	+$908K	0.72%	46
2022 Q1	$6.19M	Sell	150,000 -50,000	-25%	-$1.76M	0.61%	55
2021 Q4	$8.66M	Buy	200,000 +54,000	+37%	+$2.7M	0.58%	58
2021 Q3	$8.03M	Hold	146,000	–	–	0.56%	54
2021 Q2	$6.99M	Hold	146,000	–	–	0.47%	69
2021 Q1	$7.39M	Buy	146,000 +21,000	+17%	+$1.17M	0.52%	59
2020 Q4	$7.87M	Sell	125,000 -15,000	-11%	-$931K	0.64%	55
2020 Q3	$9.41M	Hold	140,000	–	–	0.84%	47
2020 Q2	$5.87M	Sell	140,000 -35,000	-20%	-$1.34M	0.63%	57
2020 Q1	$5.51M	Sell	175,000 -34,381	-16%	-$1.38M	0.77%	49
2019 Q4	$8.46M	Buy	209,381 +84,381	+68%	+$2.95M	0.93%	47
2019 Q3	$4.07M	Buy	+125,000	New	+$4.98M	0.51%	61

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Rhenman & Partners Asset Management's SILK Position: Q2 2023 in Review

Rhenman & Partners Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 221,255 shares — an estimated $8.61M sold.

Rhenman & Partners Asset Management first reported a position in SILK in Q3 2019 and held it in 15 quarters. The position peaked at $10.4M in Q4 2022. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

Rhenman & Partners Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Rhenman & Partners Asset Management sold 221,255 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $8.61M.
Rhenman & Partners Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 15 quarters.
Rhenman & Partners Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $10.4M in Q4 2022.
173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.